PIP4K2: A Potential Drug Target and Biomarker (P47346)

Target Name: Phosphatidylinositol-5-phosphate 4-kinase

NCBI ID: P47346

Phosphatidylinositol-5-phosphate 4-kinase

Other Name(s): PIP4K2

PIP4K2: A Potential Drug Target and Biomarker

Phosphatidylinositol-5-phosphate 4-kinase (PIP4K2) is an enzyme that plays a crucial role in cellular signaling. It is a key player in the PI3K/Akt signaling pathway, which is involved in various cellular processes such as cell growth, differentiation, and survival. PIP4K2 is highly expressed in many tissues and is considered as a potential drug target or biomarker.

PIP4K2 is a protein that catalyzes the conversion of phosphatidylinositol-4-phosphate (PIP4) to phosphatidylinositol-5-phosphate (PIP5) with the production of inositol and a phosphatidyl group. This reaction is the first step in the PI3K/Akt signaling pathway, which is a well-established pathway that regulates various cellular processes. The PI3K/Akt signaling pathway is a highly conserved signaling pathway that is involved in many cellular processes, including cell growth, differentiation, and survival.

PIP4K2 is highly expressed in various tissues, including brain, heart, and muscle. It is also expressed in various cell types, including neurons, endothelial cells, and epithelial cells. PIP4K2 is a protein that can be targeted by small molecules, including inhibitors.

One of the potential benefits of targeting PIP4K2 is its potential as a drug. PIP4K2 is involved in many cellular processes, including cell signaling, which makes it an attractive target for small molecules that can modulate cellular signaling. inhibitors of PIP4K2 have been shown to have various therapeutic effects, including the inhibition of cancer cell growth and the inhibition of neurodegenerative diseases.

Another potential application of PIP4K2 is its potential as a biomarker. The PI3K/Akt signaling pathway is involved in many cellular processes, including cell growth, differentiation, and survival. Therefore, changes in the expression of PIP4K2 may indicate changes in cellular signaling. Several studies have shown that changes in the expression of PIP4K2 are associated with various diseases, including cancer and neurodegenerative diseases. Therefore, PIP4K2 may be a useful biomarker for the diagnosis and treatment of these diseases.

In conclusion, PIP4K2 is a protein that plays a crucial role in cellular signaling and has been identified as a potential drug target or biomarker. The PI3K/Akt signaling pathway is a highly conserved signaling pathway that is involved in many cellular processes, including cell growth, differentiation, and survival. The inhibition of PIP4K2 has been shown to have various therapeutic effects, including the inhibition of cancer cell growth and the inhibition of neurodegenerative diseases. Therefore, PIP4K2 may be a valuable target for small molecules that can modulate cellular signaling and may be a useful biomarker for the diagnosis and treatment of various diseases.

Protein Name: Phosphatidylinositol-5-phosphate 4-kinase (nonspecified Subtype)

The "Phosphatidylinositol-5-phosphate 4-kinase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phosphatidylinositol-5-phosphate 4-kinase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets